Cortical microcircuits in schizophrenia - The dopamine hypothesis revisited

Pharmacopsychiatry

Volumn 39, Issue SUPPL. 1, 2006, Pages

  Winterer, Georg ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; NEUROLEPTIC AGENT;

ARTICLE; BRAIN FUNCTION; DOPAMINERGIC TRANSMISSION; HUMAN; HYPOTHESIS; NEUROSCIENCE; PREFRONTAL CORTEX; PRIORITY JOURNAL; RECEPTOR BLOCKING; SCHIZOPHRENIA; SIGNAL NOISE RATIO; STIMULUS RESPONSE;

CEREBRAL CORTEX; DOPAMINE; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; HUMANS; INTERNAL-EXTERNAL CONTROL; NERVE NET; NEURAL INHIBITION; PREFRONTAL CORTEX; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SYNAPSES;

EID: 33644832181     PISSN: 01763679     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-931498     Document Type: Article

References (18)

1. Carlsson A. Historical aspects and future directions. In: Kapur S, Lecrubier Y, eds. Dopamine in the pathophysiology and treatment of schizophrenia Martin Dunitz, London: 2003: 1-14
2. Winterer G, Weinberger DR. Schizophrenia: Genes, dopamine and cortical signal-to-noise ratio in schizophrenia. Trends in Neurosci 2004; 27: 683-690
3. Winterer G, Ziller M, Dorn H, Frick K, Wuebben Y, Mulert C, Herrmann WM, Coppola R. Schizophrenia: Reduced signal-to-noise ratio and impaired phase-locking during information processing. Clin Neurophysiol 2000; 111: 837-849
4. Winterer G, Coppola R, Goldberg TE, Egan MF, Jones DW, Sanchez CE, Weinberger DR. Prefrontal broadband noise, working memory & genetic risk for schizophrenia. Am J Psychiat 2004; 161: 1-11
5. Winterer G, Musso F, Beckmann C, Mattay V, Egan MF, Jones DW, Callicott JH, Coppola R, Weinberger DR. Instability of prefrontal BOLD-response in schizophrenia. Am J Psychiat (in press).
6. Winterer G, Egan MF, Kolachana BS, Goldberg TE, Coppola R, Weinberger DR. Prefrontal noise and COMT genotype pattern in schizophrenia. Biol Psychiatry (in press).
7. Durstewitz D, Seamans JK, Sejnowski TJ. Neurocomputational models of working memory. Nat Neurosci 2000; 3 Suppl: 1184-1191
8. Durstewitz D, Seamans JK. The computational role of dopamine D1 receptors in working memory. Neural Netw 2002; 15: 561-572
9. 1 receptors in prefrontal cortex. Nature 1995; 376: 572-575
10. Peters Y, Barnhardt NE, O'Donnell P. Prefrontal cortical up states are synchronized with ventral tegmental area activity. Synapse 2004; 52: 143-152
11. Seamans JK, Durstewitz D, Christie BR, Stevens CF, Sejnowski TJ. Dopamine D1/D5 receptor modulation of excitatory synaptic inputs to layer V prefrontal cortex neurons. Proc Natl Acad Sci USA 2001; 98: 301-306
12. Wang J, O'Donnell P. D(1) dopamine receptors potentiate NMDA-mediated excitability increase in layer V prefrontal cortical pyramidal neurons. Cereb Cortex 2001; 11: 452-462
13. Seamans JK, Gorelova N, Durstewitz D, Yang CR. Bidirectional dopamine modulation of GABAergic inhibition in prefrontal cortical pyramidal neurons. J Neurosci 2001; 21: 3628-3638
14. Meltzer H. Multiple neurotransmitters involved in antipsychotic action. In: Kapur S & Lecrubier Y, eds. Dopamine in the Pathophysiology and Treatment of Schizophrenia Martin Dunitz, London: 2003: 177-206
15. Keefe RS, Young CA, Rock SL, Purdon SE, Gold JM, Breier A. One-year double-blind study of the neurocognitive efficacy of olanzapine, risperidone, and haloperidol in schizophrenia. Schizophr Res, 2005; Sep 30 [Epub ahead of print]
16. 108/158 Met genotype and olanzapine treatment on prefrontal cortical function in patients with schizophrenia. Am J Psychiatry 2004; 161: 1798-1805
17. Daniel DG, Weinberger DR, Jones DW, Zigun JR, Coppola R, Handel S, Bigelow LB, Goldberg TE, Berman KF, Kleinman JE. The effect of amphetamine on regional cerebral blood flow during cognitive activation in schizophrenia. J Neurosci 1991; 11: 1907-1917
18. Anderer P, Saletu B, Semlitsch H, Pascual-Marqui RD. Perceptual and cognitive event-related potentials in neuropsychopharmacology: methodological aspects and clinical applications (pharmaco-ERP topography and tomography). Methods Find Exp Clin Pharmacol 2002; 24(Suppl. C): 121-137